Trump 'emboldened' by Trump Organization indictment, adviser says


Former President Donald Trump is feeling "emboldened" as charges are brought against his business and its CFO, according to one adviser.
A Manhattan grand jury on Wednesday filed criminal indictments against the Trump Organization and its chief financial officer, Allen Weisselberg, who on Thursday surrendered to face charges. The indictments are still sealed. The former president, Politico reports, was on a conference call with advisers Monday when he received word of the impending indictments, learning that he wouldn't personally be charged, and he was reportedly "thrilled by what he saw as light charges." His attention reportedly then turned to the 2024 presidential race.
"Just wait until 2024, you'll see," Trump reportedly said, suggesting the charges would be seen as a witch hunt against him.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
One adviser on the call "had the impression" that Trump "was emboldened by the news," Politico writes, with the adviser saying, "Now he's definitely going to run for president." Trump told Fox News Wednesday that he's already made up his mind about whether to run in 2024.
The New York Times' Maggie Haberman told CNN, though, that she's "not convinced" by this idea that the charges will motivate Trump to run again, nor does she think Trump actually has decided whether to do so yet.
"If he is dealing with the reality of a trial in say 18 months … it's hard to see somebody running for president with a trial playing out about how their company did business with potentially damaging testimony," she said.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Nvidia: unstoppable force, or powering down?
Talking Point Sales of firm's AI-powering chips have surged above market expectations –but China is the elephant in the room
-
5 hard-working cartoons about Labor Day celebrations
Cartoons Artists take on creation of AI, spelling mistakes, and more
-
Crossword: September 7, 2025
The Week's daily crossword puzzle
-
Why are Trump's health rumors about more than just presidential fitness?
TODAY'S BIG QUESTION Extended absences and unexplained bruises have raised concerns about both his well-being and his administration's transparency
-
'The McDonald's menu board is one fascinating thing'
Instant Opinion Opinion, comment and editorials of the day
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mount
Speed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers
-
Epstein accusers urge full file release, hint at own list
speed read A rally was organized by Reps. Ro Khanna and Thomas Massie, who are hoping to force a vote on their Epstein Files Transparency Act
-
Court hands Harvard a win in Trump funding battle
Speed Read The Trump administration was ordered to restore Harvard's $2 billion in research grants
-
Florida aims to end all state vaccine requirements
Speed Read Health Secretary Robert F. Kennedy Jr. continues to cut vaccine access and install anti-vaccine activists at the FDA and CDC